pemetrexed,carboplatin,paclitaxel,vinorelbine,nivolumab,cisplatin,docetaxel,gemcitabine,ipilimumab,pembrolizumab
merck,bms
[]
 as usual you are spot
Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own